Harmony Biosciences Stock Falls On FDA Setback For Pitolisant In Sleeping Disorder Harmony Biosciences' FDA setback for pitolisant in idiopathic hypersomnia doesn't impact its 2025 revenue outlook ...

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the ...

Explore Harmony Gold Mining Co stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for HMY. Simply Good Foods, Pacific Biosciences of California, Kura Sushi ...

In a report released today, Graig Suvannavejh from Mizuho Securities maintained a Buy rating on Harmony Biosciences Holdings (HRMY – Research Report), with a price target of $44.00. The company ...

11 analysts have expressed a variety of opinions on Harmony Biosciences Hldgs (NASDAQ:HRMY) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below ...